Of chloroquine and COVID-19
F Touret, X de Lamballerie - Antiviral research, 2020 - Elsevier
Recent publications have brought attention to the possible benefit of chloroquine, a broadly
used antimalarial drug, in the treatment of patients infected by the novel emerged …
used antimalarial drug, in the treatment of patients infected by the novel emerged …
SARS-CoV-2/COVID-19: viral genomics, epidemiology, vaccines, and therapeutic interventions
The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that
impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic …
impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic …
In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS …
X Yao, F Ye, M Zhang, C Cui, B Huang… - Clinical infectious …, 2020 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke
out in 2019 and subsequently spread worldwide. Chloroquine has been sporadically used …
out in 2019 and subsequently spread worldwide. Chloroquine has been sporadically used …
Chloroquine and hydroxychloroquine in covid-19
RE Ferner, JK Aronson - Bmj, 2020 - bmj.com
TheBMJ in 1925 cautiously endorsed Moellgaard's gold treatment for tuberculosis, 1
although it found his pharmacological reasoning “both interesting and instructive.” 2 We …
although it found his pharmacological reasoning “both interesting and instructive.” 2 We …
A broad-spectrum virus-and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
H Zhao, KKW To, KH Sze, TTM Yung, M Bian… - Nature …, 2020 - nature.com
The 2019 novel respiratory virus (SARS-CoV-2) causes COVID-19 with rapid global
socioeconomic disruptions and disease burden to healthcare. The COVID-19 and previous …
socioeconomic disruptions and disease burden to healthcare. The COVID-19 and previous …
[HTML][HTML] Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
Abstract The rapidly spreading Coronavirus Disease (COVID-19) pandemic, caused by the
severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents an …
severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents an …
[HTML][HTML] COVID-19: an update on diagnostic and therapeutic approaches
M Iyer, K Jayaramayya, MD Subramaniam, SB Lee… - BMB …, 2020 - ncbi.nlm.nih.gov
The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused
severe panic among people worldwide. COVID-19 has created havoc, and scientists and …
severe panic among people worldwide. COVID-19 has created havoc, and scientists and …
[PDF][PDF] Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives-A better synergy for future COVID-19 clinical …
MO Shittu, OI Afolami - Infez Med, 2020 - academia.edu
SUMMARY chloroquine and hydroxychloroquine, of which mechanism of action is not
completely understood. We seek to draw the attention of the scientific community to the …
completely understood. We seek to draw the attention of the scientific community to the …
COVID-19 therapeutic options under investigation
M Kaddoura, M AlIbrahim, G Hijazi… - Frontiers in …, 2020 - frontiersin.org
Since its emergence in China in December 2019, COVID-19 has quickly spread around the
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
L Zou, L Dai, X Zhang, Z Zhang, Z Zhang - Archives of pharmacal research, 2020 - Springer
A novel coronavirus, later named SARS-CoV-2, was first reported in China in December
2019 and subsequently widely identified in the United States, Japan, South Korea, France …
2019 and subsequently widely identified in the United States, Japan, South Korea, France …